GUARALDI, Gian Paolo
 Distribuzione geografica
Continente #
NA - Nord America 319
EU - Europa 91
AS - Asia 80
Totale 490
Nazione #
US - Stati Uniti d'America 317
SG - Singapore 44
CN - Cina 34
IT - Italia 30
DE - Germania 17
SE - Svezia 13
FI - Finlandia 9
GB - Regno Unito 8
BE - Belgio 6
CZ - Repubblica Ceca 3
CA - Canada 2
RU - Federazione Russa 2
IM - Isola di Man 1
IN - India 1
LT - Lituania 1
NL - Olanda 1
TR - Turchia 1
Totale 490
Città #
Chandler 44
Santa Clara 38
Singapore 37
Fairfield 33
Ashburn 32
Beijing 20
Houston 16
Seattle 14
Bremen 10
Milan 10
Princeton 10
Shanghai 10
Woodbridge 9
Helsinki 8
Wilmington 8
Cambridge 7
San Diego 7
Ferrara 6
London 6
Brussels 5
Ann Arbor 4
Augusta 4
Falkenstein 4
Boardman 3
Addison 2
Frankfurt am Main 2
Los Angeles 2
Olomouc 2
Dalian 1
Douglas 1
Falls Church 1
Forlì 1
Grosseto 1
Handan 1
Hounslow 1
Lappeenranta 1
Napoli 1
Norwalk 1
Ottawa 1
Pisa 1
Pordenone 1
Prague 1
Redmond 1
Rome 1
San Mateo 1
Shenzhen 1
Stockholm 1
Toronto 1
Verona 1
Wandsworth 1
Washington 1
Totale 376
Nome #
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 76
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 70
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 59
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 56
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 55
Virological response to treatment in patient who start raltegravir in combination with newer agents in current clinical practice 45
Serious liver events and liver-related deaths in HIV/HCV co-infected patients with diabetes: data from the ICONA Foundation Cohort Study. 38
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 38
Three-years follow up of raltegravir and/or maraviroc-based regimens in patients experienced to PI, NRTI, NNRTI. Update from the ISS-NIA cohort 36
Low Body Mass Index (BMI) in ART naïve HIV-positive subjects and risk of virologic failure and drug discontinuation: data from the ICONA Foundation cohort. 29
Totale 502
Categoria #
all - tutte 4.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 0 0 0 0 29 15 14 4
2020/202183 3 16 6 8 7 10 4 6 2 7 9 5
2021/202271 3 6 0 1 8 4 1 2 3 9 1 33
2022/2023103 11 14 6 11 19 10 10 6 9 0 7 0
2023/202460 2 9 3 4 6 11 0 6 2 0 1 16
2024/2025123 5 2 20 17 34 44 1 0 0 0 0 0
Totale 502